- Treatment & Clinical Trials
- In the News
- Current Research
- Archives: News & Trials
Treatment & Clinical Trials
Has someone in your household recently been diagnosed with COVID-19? Volunteer for a Clinical Trial. University of Minnesota is enrolling volunteers in a research study for individuals living with someone who recently tested positive for COVID-19. Learn More
Dr. David Boulware's hydroxychloroquine trial on early outpatient treatment of COVID-19 has been published in the Annals of Internal Medicine. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Dr. David Boulware discusses his Hydroxychloroquine trial on Open Forum Infectious Diseases podcast. How to Conduct a Clinical Trial During a Pandemic—An Interview with Dr. David Boulware
In the News
Dr. David Boulware, MD, MPH is interviewed on CNN with Sanjay Gupta, MD on a promising drug Fluvoxamine in preventing symptoms of COVID-19, Watch "Everything old is new again: Repurposing drugs to treat Covid-19".
Dr. David Boulware is quoted in the Associated Press about the lack of scientific evidence behind a “miracle” treatment touted by Venezuela’s president. Read Article
Dr. Susan Kline shares with the Milwaukee Journal Sentinel her take on "International team of scientists identifies new treatment for COVID-19 that appears to be far more effective than drugs in use now" Read more
Dr. Susan Kline interviewed on Fox 9 News, "University of Minnesota seeks volunteers for COVID-19 vaccine trial". Watch Interview
Dr. Timothy Schacker discusses COVID Vaccine developments at the University of Minnesota. Watch Here
University of Minnesota establishes the National Resource Center for Refugees, Immigrants and Migrants. Lead by Dr. William Stauffer (Infectious Diseases) and co-lead by Dr. Shailey Prasad (Family Medicine) to address worsening health disparities in RIM populations caused by the COVID-19 pandemic. Read Feature ∙ Read Sahan Journal.
Dr. David Boulware interviews with ABC Popular antidepressant shows promise as COVID-19 treatment. View Feature.
Dr. Radha Rajasingham: University of Minnesota Trial Shows Hydroxychloroquine Does Not Prevent COVID-19 in High-Risk Health Care Workers. Read Feature.
Dr. Susan Kline, Using Science to Find Solutions. Read Feature.
Minnesota Monthly honors Dr. Winston Cavert, Dr. Susan Kline, Dr. Meghan Rothenberber and Dr. Jo-Anne Young in 2020 Top Doctors.
Christen Ebens, MD, MPH, in the Department of Pediatrics, and Meghan Rothenberger, MD, in the Department of Medicine, co-lead the U of M site for an international study collecting samples from some of COVID-19’s most unexpected, yet sickest, patients. The research will determine if genetics plays a role in who falls ill with the disease. Read Story.
Dr. Joshua Rhein discusses with Star Tribune, natural killer cells also have antiviral properties that could work against COVID-19. View Feature.
Dr. Tyler Bold’s Lab is conducting research on antibody prevention of reinfection in his study SERUM SARS-COV-2 NEUTRALIZATION ACTIVITY. Learn More
A study led by Infectious Diseases Dr. Geoffrey Hart and Dr. Marco Pravetoni (Pharmacology): Understanding Protective Antibody Mechanisms in COVID-19 to Engineer Universal Coronavirus Vaccine. Learn More
Archives: News & Trials
About our Division
- Talented Faculty
- Opportunities for Fellows
- Think & Act Globally
The Division of Infectious Diseases and International Medicine (IDIM) has more than 50 faculty overseeing programs in clinical care, education, and research at five teaching hospitals affiliated with the University of Minnesota Medical School: University of Minnesota Medical Center (UMMC), Minneapolis VA Health Care System, Hennepin County Medical Center, Regions Hospital, and Abbott Northwestern Hospital.
Each of these institutions serves somewhat different patient populations, and the clinical and research programs at these sites together with opportunities in global health, provide a remarkable breadth of expertise and academic experiences for trainees in the IDIM Division.
Research & Collaboration
In addition to our clinical scholars and physician scientists with clinical responsibilities, five full-time research faculty contribute importantly to the research mission of our division. The Center for Infectious Diseases and Microbiology Translational Research, an interdisciplinary research center, is the base of operation for these faculty members. Epidemiological research is carried out with colleagues in the School of Public Health, which helps administrate the division’s NIH-funded MPH/MSc-related training program. The Division also benefits from collaborations with faculty members who hold joint academic appointments in other departments, colleagues in the Center for Infectious Diseases Research and Policy, the College of Veterinary Medicine, the Minnesota Department of Health, and a number of community-based Infectious Diseases faculty.
Opportunities for Fellows
Opportunities for Fellows
During their research training, Infectious Diseases Fellows can enter an NIH-supported epidemiology (MPH)/clinical research (MSc) pathway coordinated by the School of Public Health, or they can select a laboratory-based research project at several training sites, including the Center for Translational Research in Microbiology and Infectious Diseases.
Think & Act Globally
Think & Act Globally
Because of a large influx of immigrants to Minnesota and increasing challenges from emerging infections here and abroad, especially in developing countries, our goal is to: "Think and act locally and globally."
About this Conference
The ID Intercity Clinical Case Conference is a regularly scheduled didactic session, sponsored by the Infectious Diseases Division in the Department of Medicine. Presenters are invited from the University of Minnesota, the Minnesota Department of Health and the ID community.
Held weekly on Tuesday mornings throughout the year (with the exception of July), case presentations are interactive and frequently presented as “unknowns,” encouraging discovery and participation with the audience in diagnosis and treatment remedies. Fellows, residents, students, faculty and members of the ID community all present and participate. This series is open to the public and sessions are streamed live and often recorded.
Dr. Jo-Anne Young is the conference director and Betsy Wehrwein is the organizer. For further information, please contact email@example.com.